Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Current Deferred Revenue readings, the most recent being $2.2 billion for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 13.98% to $2.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.2 billion, a 13.98% increase, with the full-year FY2025 number at $2.1 billion, up 7.82% from a year prior.
  • Current Deferred Revenue hit $2.2 billion in Q1 2026 for GE HealthCare Technologies, up from $2.1 billion in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $2.7 billion in Q2 2025 to a low of $1.9 billion in Q1 2024.
  • Median Current Deferred Revenue over the past 5 years was $2.0 billion (2023), compared with a mean of $2.1 billion.
  • Biggest five-year swings in Current Deferred Revenue: soared 38.34% in 2023 and later fell 25.92% in 2024.
  • GE HealthCare Technologies' Current Deferred Revenue stood at $1.9 billion in 2022, then skyrocketed by 38.34% to $2.6 billion in 2023, then fell by 25.92% to $1.9 billion in 2024, then rose by 7.82% to $2.1 billion in 2025, then increased by 2.77% to $2.2 billion in 2026.
  • The last three reported values for Current Deferred Revenue were $2.2 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025) per Business Quant data.